MedPath

IASO Pharma, Inc.

IASO Pharma, Inc. logo
🇺🇸United States
Ownership
Private
Established
2006-01-01
Employees
11
Market Cap
-
Website

Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia

Phase 2
Terminated
Conditions
Community Acquired Pneumonia
Interventions
First Posted Date
2010-03-05
Last Posted Date
2012-05-07
Lead Sponsor
IASO Pharma Inc.
Target Recruit Count
48
Registration Number
NCT01081964
© Copyright 2025. All Rights Reserved by MedPath